Help | RSS Feed

Taxus Cardium Pharmaceuticals Group, Inc. (OTCMKT:CRXM) Seasonal Chart

CRXM Relative to the S&P 500
CRXM Relative to the S&P 500

CRXM Relative to the Sector
CRXM Relative to the Sector

Monthly Seasonal Taxus Cardium Pharmaceuticals Group, Inc. (OTCMKT:CRXM)

Seasonal Chart Analysis

Analysis of the Taxus Cardium Pharmaceuticals Group, Inc. (OTCMKT:CRXM) seasonal charts above shows that a Buy Date of December 28 and a Sell Date of April 3 has resulted in a geometric average return of 3.18% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a poor rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 34.7% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Gene Biotherapeutics Inc, formerly known as Taxus Cardium Pharmaceuticals Group Inc is an operating company which manages medical technologies portfolio. Its investment portfolio includes Angionetics, which focuses on late-stage clinical development and commercialization of Generx, an angiogenic gene therapy product candidate designed for medical treatment of myocardial ischemia and refractory angina; Activation Therapeutics focuses on the development and commercialization of the Excellagen, which is a flowable dermal matrix technology platform for small molecule drugs, proteins, and biologics.

To download CRXM seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z